Search Results

There are 7648 results for: content related to: Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies

  1. Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis


    Volume 110, Issue 4, April 2015, Pages: 572–584, Isabel Tavitian-Exley, Peter Vickerman, Francisco I. Bastos and Marie-Claude Boily

    Version of Record online : 15 MAR 2015, DOI: 10.1111/add.12846

  2. Oral substitution treatment of injecting opioid users for prevention of HIV infection

    Intervention Review

    The Cochrane Library

    Linda Gowing, Michael F Farrell, Reinhard Bornemann, Lynn E Sullivan and Robert Ali

    Published Online : 10 AUG 2011, DOI: 10.1002/14651858.CD004145.pub4

  3. You have free access to this content
    Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?

    British Journal of Clinical Pharmacology

    Volume 77, Issue 2, February 2014, Pages: 272–284, Maria Paz Garcia-Portilla, Maria Teresa Bobes-Bascaran, Maria Teresa Bascaran, Pilar Alejandra Saiz and Julio Bobes

    Version of Record online : 22 JAN 2014, DOI: 10.1111/bcp.12031

  4. Heroin maintenance for chronic heroin-dependent individuals

    Intervention Review

    The Cochrane Library

    Marica Ferri, Marina Davoli and Carlo A. Perucci

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD003410.pub4

  5. Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 778–787, Marie Claire Van Hout

    Version of Record online : 11 MAR 2014, DOI: 10.1002/dta.1622

  6. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic


    Volume 98, Issue 6, June 2003, Pages: 749–760, María J. Bravo, Gregorio Barrio, Luis De La Fuente, Luis Royuela, Laura Domingo and Teresa Silva

    Version of Record online : 22 MAY 2003, DOI: 10.1046/j.1360-0443.2003.00393.x

  7. You have free access to this content
    The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review

    Health & Social Care in the Community

    Rebekah Brennan, John S.G. Wells and Marie Claire Van Hout

    Version of Record online : 25 JAN 2016, DOI: 10.1111/hsc.12326

  8. You have free access to this content
    Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use

    Alimentary Pharmacology & Therapeutics

    Volume 29, Issue 1, January 2009, Pages: 29–37, M. WILKINSON, V. CRAWFORD, A. TIPPET, F. JOLLY, J. TURTON, E. SIMS, M. HEKKER, J. DALTON, R. MARLEY and G. R. FOSTER

    Version of Record online : 26 AUG 2008, DOI: 10.1111/j.1365-2036.2008.03834.x

  9. You have full text access to this OnlineOpen article
    Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users


    Volume 102, Issue 9, September 2007, Pages: 1454–1462, Charlotte Van Den Berg, Colette Smit, Giel Van Brussel, Roel Coutinho and Maria Prins

    Version of Record online : 9 AUG 2007, DOI: 10.1111/j.1360-0443.2007.01912.x

  10. You have full text access to this OnlineOpen article
    The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015


    Volume 111, Issue 1, January 2016, Pages: 34–48, Jane Mounteney, Paul Griffiths, Roumen Sedefov, Andre Noor, Julián Vicente and Roland Simon

    Version of Record online : 30 SEP 2015, DOI: 10.1111/add.13056

  11. A prospective study of hepatitis C incidence in Australian prisoners


    Volume 109, Issue 10, October 2014, Pages: 1695–1706, Fabio Luciani, Neil Arvin Bretaña, Suzy Teutsch, Janaki Amin, Libby Topp, Gregory J. Dore, Lisa Maher, Kate Dolan, Andrew R. Lloyd and on behalf of the HITS-p investigators

    Version of Record online : 15 JUL 2014, DOI: 10.1111/add.12643

  12. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents

    Liver International

    Volume 34, Issue 8, September 2014, Pages: 1198–1206, Maryam Alavi, Jesse D. Raffa, Gregory D. Deans, Calvin Lai, Mel Krajden, Gregory J. Dore, Mark W. Tyndall and Jason Grebely

    Version of Record online : 20 NOV 2013, DOI: 10.1111/liv.12370

  13. You have free access to this content
    Negotiating access to medical treatment and the making of patient citizenship: the case of hepatitis C treatment

    Sociology of Health & Illness

    Volume 35, Issue 7, September 2013, Pages: 1023–1044, Tim Rhodes, Magdalena Harris and Anthea Martin

    Version of Record online : 24 MAY 2013, DOI: 10.1111/1467-9566.12018

  14. Risk adjustment of heroin treatment outcomes for comparative performance assessment in England


    Volume 107, Issue 12, December 2012, Pages: 2161–2172, John Marsden, Brian Eastwood, Hayley Jones, Colin Bradbury, Matthew Hickman, Jonathan Knight, Kulvir Randhawa, Martin White and the National Drug Treatment Monitoring System Outcomes Study Group

    Version of Record online : 10 AUG 2012, DOI: 10.1111/j.1360-0443.2012.03971.x

  15. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study


    Volume 111, Issue 2, February 2016, Pages: 311–319, Jason Grebely, Maryam Alavi, Michelle Micallef, Adrian J. Dunlop, Anne C. Balcomb, Nghi Phung, Martin D. Weltman, Carolyn A. Day, Carla Treloar, Nicky Bath, Paul S. Haber, Gregory J. Dore and on behalf of the ETHOS Study Group

    Version of Record online : 25 NOV 2015, DOI: 10.1111/add.13197

  16. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study

    HIV Medicine

    Volume 16, Issue 3, March 2015, Pages: 137–151, R Weber, M Huber, M Battegay, C Stähelin, E Castro Batanjer, A Calmy, A Bregenzer, E Bernasconi, F Schoeni-Affolter, B Ledergerber and the Swiss HIV Cohort Study

    Version of Record online : 15 AUG 2014, DOI: 10.1111/hiv.12184

  17. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates


    Volume 107, Issue 6, June 2012, Pages: 1111–1122, Gregorio Barrio, María J. Bravo, M. Teresa Brugal, Mercedes Díez, Enrique Regidor, María José Belza, Luis de la Fuente and the Itinere Working Group

    Version of Record online : 11 FEB 2012, DOI: 10.1111/j.1360-0443.2011.03759.x

  18. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning


    Volume 104, Issue 12, December 2009, Pages: 2049–2056, Handan Wand, Donna Spiegelman, Matthew Law, Bin Jalaludin, John Kaldor and Lisa Maher

    Version of Record online : 5 OCT 2009, DOI: 10.1111/j.1360-0443.2009.02704.x

  19. Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users

    Journal of Viral Hepatitis

    Volume 21, Issue 8, August 2014, Pages: e65–e73, P. B. Sugden, B. Cameron, F. Luciani, A. R. Lloyd and on behalf ofthe HITS investigators

    Version of Record online : 26 FEB 2014, DOI: 10.1111/jvh.12232

  20. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study


    Volume 101, Issue 2, February 2006, Pages: 252–266, Tim Rhodes, Lucy Platt, Svetlana Maximova, Evgeniya Koshkina, Natalia Latishevskaya, Matthew Hickman, Adrian Renton, Natalia Bobrova, Tamara McDonald and John V. Parry

    Version of Record online : 24 JAN 2006, DOI: 10.1111/j.1360-0443.2006.01317.x